Hikma Pharmaceuticals · 1 day ago
Co-Op Intern-Documentation Specialist:
Hikma Pharmaceuticals is a leading pharmaceutical company, and they are seeking a Co-Op Intern for the Documentation Specialist role. The intern will be responsible for reviewing Master Batch Records, drafting and reviewing documents, and participating in process improvement projects.
Health CareMedicalPharmaceutical
Responsibilities
Review of Master Batch Records
Participation in scanning and managing of Master Batch Records
Drafts, reviews and word processes revised documents requiring revision or creation
Review and approves documentation for accuracy and compliance to procedures
Participates in process improvement projects
Work with cross-functional teams and follow-up on documentation related projects
Create and Maintain databases to track status of documents, maintain original documents
Qualification
Required
Review of Master Batch Records
Participation in scanning and managing of Master Batch Records
Drafts, reviews and word processes revised documents requiring revision or creation
Review and approves documentation for accuracy and compliance to procedures
Participates in process improvement projects
Work with cross-functional teams and follow-up on documentation related projects
Create and Maintain databases to track status of documents, maintain original documents
Company
Hikma Pharmaceuticals
Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products
H1B Sponsorship
Hikma Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (16)
2024 (23)
2023 (22)
2022 (24)
2021 (28)
2020 (18)
Funding
Current Stage
Public CompanyTotal Funding
$250MKey Investors
International Finance Corporation
2025-07-15Post Ipo Debt· $250M
2005-11-04IPO
Recent News
2026-01-09
London Evening Standard
2025-12-16
2025-12-15
Company data provided by crunchbase